Your browser doesn't support javascript.
loading
Long-term analysis of cellular immunity in patients with RRMM treated with CAR-T cell therapy.
Cheng, Hai; Ji, Shengwei; Wang, Jiaojiao; Hua, Tian; Chen, Zihan; Liu, Jiaying; Shao, Lingyan; Wang, Xue; Chen, Wei; Sang, Wei; Qi, Kunming; Li, Zhenyu; Sun, Cai; Shi, Ming; Qiao, Jianlin; Wu, Qingyun; Zeng, Lingyu; Fei, Xiaoming; Huang, Hongming; Gu, Weiying; Xu, Kailin; Zheng, Junnian; Cao, Jiang.
Afiliación
  • Cheng H; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.
  • Ji S; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.
  • Wang J; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.
  • Hua T; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.
  • Chen Z; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.
  • Liu J; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.
  • Shao L; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.
  • Wang X; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.
  • Chen W; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.
  • Sang W; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.
  • Qi K; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.
  • Li Z; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.
  • Sun C; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.
  • Shi M; Cancer Institute, Xuzhou Medical University, Xuzhou, 221002, China.
  • Qiao J; Jiangsu Bone Marrow Stem Cell Institute, Xuzhou, 221002, China.
  • Wu Q; Jiangsu Bone Marrow Stem Cell Institute, Xuzhou, 221002, China.
  • Zeng L; Jiangsu Bone Marrow Stem Cell Institute, Xuzhou, 221002, China.
  • Fei X; Department of Hematology, The Affiliated Hospital of Jiangsu University, Zhenjiang, 212000, China.
  • Huang H; Department of Hematology, The Affiliated Hospital of Nantong University, Nantong, 226000, China.
  • Gu W; Department of Hematology, The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou, 213000, China.
  • Xu K; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China. lihmd@163.com.
  • Zheng J; Cancer Institute, Xuzhou Medical University, Xuzhou, 221002, China. jnzheng@xzhmu.edu.cn.
  • Cao J; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China. zimu05067@163.com.
Clin Exp Med ; 23(8): 5241-5254, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37907623
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / Mieloma Múltiple Límite: Humans Idioma: En Revista: Clin Exp Med Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / Mieloma Múltiple Límite: Humans Idioma: En Revista: Clin Exp Med Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: China